LFCO human leukocyte antigen DRB1 site typing reagent - Taiwan Registration 23661f63b8de4e4490efe2924a1149d9
Access comprehensive regulatory information for LFCO human leukocyte antigen DRB1 site typing reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 23661f63b8de4e4490efe2924a1149d9 and manufactured by IMMUCOR GTI DIAGNOSTICS, INC.. The authorized representative in Taiwan is METEK LAB INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
DNA typing of the human leukocyte antigen dual gene DRB1.
B Hematology, pathology, and genetics
B.0001 Human leukocyte antigen typing test system
import
Dates and Status
Jan 06, 2015
Jan 06, 2030